Stribild (elvitegravir 150 mg/
cobicistat 150 mg/emtricitabine
200 mg/tenofovir disoproxil
fumarate 300 mg), an Integrase
Inhibitor based single tablet
regimen treatment for HIV, is now
available on the Pharmaceutical
Benefits Scheme.
The tablet is taken once daily and
Gilead has said it could prompt
earlier HIV treatment.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Apr 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Apr 14
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.